Reproducibility of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected individuals

被引:25
|
作者
Shafer, RW [1 ]
Warford, A [1 ]
Winters, MA [1 ]
Gonzales, MJ [1 ]
机构
[1] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA
关键词
HIV-1; protease; reverse transcriptase;
D O I
10.1016/S0166-0934(00)00144-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The reproducibility of population-based human immunodeficiency virus type 1 (HIV-I) protease and reverse transcriptase (RT) sequencing was assessed using replicate aliquots of cryopreserved plasma samples obtained from seven heavily treated HIV-1-infected individuals. The sequence of each sample replicate was compared with the consensus sequence for that sample and 99.4% of 35128 amino acids were found to be concordant with the sample consensus. Partial discordances were present at 0.5% of positions and complete discordances were present at <0.1% of positions. To assess the reproducibility at detecting mutations (defined here as differences from the subtype B consensus sequence), the proportion of sequences having a mutation when at least two sequences from that sample had the same mutation were examined. There was a median of 13 protease and 18 RT mutations per sample for a total of 3126 mutations; 95% of these mutations were detected. However, sequencing of multiple clones from two samples demonstrated that those mutations present in a minority of clones were often not detected by population-based sequencing. These results suggest that HIV-I protease and RT sequencing of circulating plasma virus is highly reproducible but that the sensitivity at detecting mutations may be low if those mutations are present as minor variants. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:143 / 153
页数:11
相关论文
共 50 条
  • [41] Inhibition of human immunodeficiency virus-1 (HIV-1) by β-chemokine analogues in mononuclear cells from HIV-1-infected patients with active tuberculosis
    Toossi, Z
    Mayanja-Kizza, H
    Baseke, J
    Peters, P
    Wu, M
    Abraha, A
    Aung, H
    Okwera, A
    Hirsch, C
    Arts, E
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 142 (02): : 327 - 332
  • [42] Human immunodeficiency virus type 1 (HIV-1) antigen secretion by latently infected resting CD4+ T lymphocytes from HIV-1-infected individuals (vol 78, pg 10536, 2004)
    Fondere, JM
    Petitjean, G
    Huguet, MF
    Salhi, SL
    Baillat, V
    Macura-Biegun, A
    Becquart, P
    Reynes, J
    Vendrell, JP
    JOURNAL OF VIROLOGY, 2004, 78 (22) : 12722 - 12722
  • [43] Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy
    Tashima, KT
    Caliendo, AM
    Ahmad, M
    Gormley, JM
    Fiske, WD
    Brennan, JM
    Flanigan, TP
    JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (03): : 862 - 864
  • [44] Phosphorothioate oligonucleotides derived from human immunodeficiency virus type 1 (HIV-1) primer tRNA(Lys3) are strong inhibitors of HIV-1 reverse transcriptase and arrest viral replication in infected cells
    ElDiraniDiab, R
    SarihCottin, L
    Delord, B
    Dumon, B
    Moreau, S
    Toulme, JJ
    Fleury, H
    Litvak, S
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (10) : 2141 - 2148
  • [45] DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) IN GENITAL ULCER EXUDATE OF HIV-1-INFECTED MEN BY CULTURE AND GENE AMPLIFICATION
    PLUMMER, FA
    WAINBERG, MA
    PLOURDE, P
    JESSAMINE, P
    DCOSTA, LJ
    WAMOLA, IA
    RONALD, AR
    JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (04): : 810 - 811
  • [46] GENERATION AND CHARACTERIZATION OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) MUTANT RESISTANT TO AN HIV-1 PROTEASE INHIBITOR
    ELFARRASH, MA
    KURODA, MJ
    KITAZAKI, T
    MASUDA, T
    KATO, K
    HATANAKA, M
    HARADA, S
    JOURNAL OF VIROLOGY, 1994, 68 (01) : 233 - 239
  • [47] Vertical transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1-infected infant
    Johnson, VA
    Petropoulos, CJ
    Woods, CR
    Hazelwood, JD
    Parkin, NT
    Hamilton, CD
    Fiscus, SA
    JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (11): : 1688 - 1693
  • [48] Detection of antisense protein (ASP) RNA transcripts in individuals infected with human immunodeficiency virus type 1 (HIV-1)
    Mancarella, Antonio
    Procopio, Francesco A.
    Achsel, Tilmann
    De Crignis, Elisa
    Foley, Brian T.
    Corradin, Giampietro
    Bagni, Claudia
    Pantaleo, Giuseppe
    Graziosi, Cecilia
    JOURNAL OF GENERAL VIROLOGY, 2019, 100 (05): : 863 - 876
  • [49] Quantitative analysis of differentially expressed saliva proteins in human immunodeficiency virus type 1 (HIV-1) infected individuals
    Zhang, Nawei
    Zhang, Zhenyu
    Feng, Shan
    Wang, Qingtao
    Malamud, Daniel
    Deng, Haiteng
    ANALYTICA CHIMICA ACTA, 2013, 774 : 61 - 66
  • [50] SUPPRESSIVE EFFECT OF POLYOXOMETALATES ON THE CYTOPATHOGENICITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) INVITRO AND THEIR INHIBITORY ACTIVITY AGAINST HIV-1 REVERSE-TRANSCRIPTASE
    INOUYE, Y
    TOKUTAKE, Y
    KUNIHARA, J
    YOSHIDA, T
    YAMASE, T
    NAKATA, A
    NAKAMURA, S
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1992, 40 (03) : 805 - 807